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Abstract
CD8 T cells play an important role in controlling viral infections. We investigated the in situ localization of simian
immunodeficiency virus (SIV)-specific T cells in lymph and genital tissues from SIV-infected macaques using MHC-class I
tetramers. The majority of tetramer-binding cells localized in T cell zones and were CD8+. Curiously, small subpopulations of
tetramer-binding cells that had little to no surface CD8 were detected in situ both early and late post-infection, and in both
vaginally and rectally inoculated macaques. These tetramer+CD8low/2 cells were more often localized in apparent B cell
follicles relative to T cell zones and more often found near or within the genital epithelium than the submucosa. Cells
analyzed by flow cytometry showed similar populations of cells. Further immunohistological characterization revealed small
populations of tetramer+CD202 cells inside B cell follicles and that tetramer+ cells did not stain with cd-TCR nor CD4
antibodies. Negative control tetramer staining indicated that tetramer+CD8low/2 cells were not likely NK cells non-
specifically binding to MHC tetramers. These findings have important implications for SIV-specific and other antigen-specific
T cell function in these specific tissue locations, and suggest a model in which antigen-specific CD8+ T cells down modulate
CD8 upon entering B cell follicles or the epithelial layer of tissues, or alternatively a model in which only antigen-specific
CD8 T cells that down-modulate CD8 can enter B cell follicles or the epithelium.
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Introduction
Rhesus macaques infected with simian immunodeficiency virus
(SIV) have been extensively and successfully used as an animal model
to help understand the immunopathogenesis of human immunode-
ficiency virus (HIV) [1,2]. Many studies have provided strong
evidence for the importance of virus-specific CD8+ T lymphocytes in
controlling viral replication in this animal model. For example, the
emergence of CD8+ cytotoxic T lymphocytes coincides with reduced
viral loads during acute infection [3,4]. Furthermore, depletion of
circulating CD8+ lymphocytes during SIV-infected macaques leads
to an increase in viremia [5,6]. For these reasons an effective HIV/
AIDS vaccine is thought to require the induction of virus-specific
CD8+ T lymphocytes [7,8]. However, we lack a complete
understanding of in vivo localization and abundance of virus-specific
CD8 T cell responses during SIV infection at the portal of virus entry
and in lymphoid tissues. Understanding SIV-specific CD8 T cell
localization will help us understand the role of virus-specific CD8 T
cells in controlling viral replication in vivo.
Antigen-specific T cells can be visualized in situ by staining
tissue sections with MHC class I tetramers [9,10]. In previous
studies, we used in situ tetramer staining to characterize antigen-
specific T cells in tissues from mice [11], primates [12–14], and
humans [15]. In situ tetramer staining allows researchers to
determine the localization of antigen-specific T cells in specific
tissue compartments, to determine the relationship of antigen-
specific T cells to other cells, and to correlate the phenotype of
antigen-specific T cells to specific tissue locations.
In our previous studies, we investigated the in situ localization of
SIV-specific T cells in tissues from rhesus macaques infected with
SIV using MHC-tetramers and found that most MHC-tetramer
stained cells were CD8+ and localized with other CD8+ T cells in
lymphoid and genital tissues [12–14,16]. During the course of
these studies, we identified subpopulations of SIV-specific T cells
that appear to have down-modulated surface expression of CD8
molecules in B cell follicles and in the vaginal and cervical
epithelium. We present these findings here and discuss the
importance of these findings to HIV and SIV infections.
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Results
Identification of unique subpopulations of
tetramer+CD8low/2 cells in situ
We investigated the localization of SIV-specific T cells stained
with MHC-class I tetramers in lymph nodes, spleen, vagina and
cervix tissues from SIV-infected Mamu-A*01 rhesus macaques. In
each tissue in which tetramer-binding cells were found most of
these cells were also CD8+ and localized in T cell zones [12,16]
(Figures 1, 2 and 3). However, we also observed small, localized
subpopulations of tetramer-binding cells that were CD8low/2
(Table 1, Figure 1, Figure 2, and Figure 3). Tetramer+CD8low/2
cells tended to be clustered together and showed a distinct
localization relative to most CD8+ T cells. In lymph nodes and
spleen tissues, tetramer+ CD8low/2 cells were frequently found in
B cell follicle-like areas–spherical areas near the cortex that
showed little to no staining with CD8 antibodies (Figure 1A–E). In
the vagina and cervix, although most tetramer staining cells were
CD8+ and located in the submucosa, small subpopulations of
tetramer+CD8low/2 cells were also detected. These cells typically
localized in areas with few CD8+ T cells in the epithelium or near
the border of submucosa (Figure 2). Some animals showed
relatively large numbers of tetramer+CD8low/2 cells in the
epithelium, whereas others showed just a few tetramer+CD8low/2
cells located near epithelium and submucosa junction (data not
shown). Both Tat28–35 SL8 (Tat SL8) and Gag181–189CM9 (Gag
CM9) tetramers stained a subpopulation of CD8low/2 cells in situ,
indicating that this subpopulation of cells was not specific for one
particular type of antigen-specific T cell (data not shown).
Quantification of unique subpopulations of
tetramer+CD8low/2 cells in situ
To further illustrate the localization and abundance of tetramer+
CD8low/2 cells, we quantified cells in different locations within
lymph node and vagina tissues in four animals (R80072, 84089,
rh1919, and 27338). In lymph node and vagina tissue sections
stained with Gag CM9 tetramers and anti-CD8 antibodies, we
scored tetramer+ cells as being CD8+, CD8low, or CD82.
Tetramer+CD8low cells were defined as cells that showed little
CD8 staining in the membrane that was just above background
levels, and tetramer+CD82 cells were defined as cells that showed
no CD8 staining in the membrane above background levels. The
location of cells within tissues was also scored. Cells in the lymph
nodes were scored as being either in a CD8 T cell rich region, or
within a region morphologically resembling a B cell follicle – a
spherical region with few CD8T cells near the cortex. In the vagina,
cells were scored as being in the submucosa, near the border of the
submucosa and epithelium or within the epithelium. The results
showed that in the lymph node most cells were tetramer+CD8+ and
these cells were most highly concentrated in the T cell rich areas;
whereas tetramer+CD82 cells were much fewer in number and
more highly concentrated in B cell follicle-like areas (Figure 3A). In
the vagina, most cells were tetramer+CD8+ cells and these cells were
most highly concentrated in the submucosa (Figure 3B). Tetra-
mer+CD8low cells were more highly concentrated in the border of
the submucosa and tetramer+CD82 cells were more highly
concentrated in the epithelium (Figure 3B). Negative control
staining was done in lymph nodes with tetramers loaded with an
irrelevant peptide for animals r80072, 84089, and rh1919, and with
no tetramer for animal 27338. We have previously found that
negative control staining with no tetramer and tetramers loaded
with an irrelevant peptide show similar results. For vagina sections,
negative control staining was done with tetramers loaded with an
irrelevant peptide for all four animals. In lymph nodes from each
animal the concentration of positively stained CD82 cells in CD8
negative regions was higher in MamuA*01/Gag CM9 stained
sections than in the negative control stained sections, with
concentrations of Gag CM9 cells showing a 1.4 to 28.4 fold
Figure 1. Localization of SIV-specific CD8low/2 T cells in lymph nodes. In each set of panels, the left panels show tetramer staining (red), the
middle panels show CD8 staining (green), and the right panels merged images of the red and green stain (A) and (D) show Mamu-A*01 Tat SL8
staining and (F) shows staining from the negative control Mamu-A*01 FLP tetramer. Panels (D) and (E) are derived from (A) and (B), but show only the
tetramer stained in order to more easily note the lack of CD8 staining on the cells in the cluster of cells in the upper right-hand quadrant of the image
delineated by the purple line. These are representative images from axillary lymph nodes from SIV-infected rhesus macaque #27357 at 20 days post-
infection. All images are confocal Z-scans collected using a 206 objective. Scale Bar = 50 microns.
doi:10.1371/journal.pone.0004131.g001
Localized CD8low/2 T Cells
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increase over negative control staining (Figure 3A). In the vagina,
when present, concentrations of Gag CM9-binding cells were
similarly substantially greater than negative control staining for each
animal (Figure 3B).
Figure 3C and D shows the percentage of tetramer+CD8+,
tetramer+CD8low, and tetramer+CD82 within each tissue region.
In the lymph nodes, the percentage of tetramer+CD8+ in CD8 rich
regions of the lymph node was significantly greater than the
percentage of tetramer+CD8+ cells in CD8 low B cell follicle-like
regions (Figure 3C). The percentage of tetramer+CD8low cells in
the lymph nodes was not significantly different in the two tissue
compartments, while the percentage of tetramer+CD82 cells was
significantly greater within the B cell follicle-like areas compared to
the CD8 T cell-rich regions of the lymph nodes (Figure 3C). In the
vagina, the percentage of tetramer+CD8+ cells within the
submucosa was significantly greater than the percentage of
tetramer+CD8+ cells near the border of the submucosa and
epithelium or in the epithelium (Figure 3D). Also, the percentage
of tetramer+CD8low cells near the border of the submucosa was
significantly greater than the percentage of cells that were
tetramer+CD8low in the submucosa (Figure 3D).
In addition, to better quantify the number of times clusters of
tetramer+CD8low/2 cells were present within B cell follicles in
lymph nodes as determined by morphology (a spherical area with
few CD8 T cells near the cortex), using a confocal microscope we
collected a z-scan image through the middle of each apparent
follicle in stained sections and scored the number of tetramer+C-
D8low/2 cells found within. The results showed that 75% (18 of 24)
B cell follicle-like areas identified showed clusters of 3 to 13
tetramer+CD8low/2 cells within. In contrast, similarly examined
negative control sections did not show any clusters of tetra-
mer+CD8low/2 cells in 18 follicle-like areas examined. Represen-
tative images are shown in Figure 1.
When we stained these sections with MamuA*01/Gag CM9
tetramers and CD20 antibodies (B cell marker) to determine
whether tetramer+ cells localized to B cell follicles, we found small
populations of tetramer+ cells in B cell follicles (Figure 4). These
data taken together with the data presented in figures 1 and 3
suggest that the tetramer+CD8low/2 cells detected in lymphoid
tissues were localized to B cell follicles.
Tetramer staining of disaggregated cells from lymph and
genital tissues
We also examined whether similar populations of tetramer+C-
D8low/2 cells were detected in disaggregated cells using flow
cytometry. The percentage of tetramer+CD82 cells was equal to
Figure 2. Localization of SIV-specific CD8low/2 T cells in the genital tract. In each set of panels, the left panels show tetramer staining (red),
the middle panels show CD8 antibody stain (green), and the right panels are merged images of the left and middle images. Mamu-A*01 Gag CM9
staining is shown in (A, D and G) and negative control Mamu-A*01 FLP is shown in (J). All panels are representative images of vagina from animal
#27338 at 28 day post-infection, with panels (D) to (F) showing a higher magnification of the area indicated by the white box in (C). White arrow
heads in (F) indicate tetramer+ CD8low T cells. White arrows indicate tetramer+CD8low/2 cells. The outer edge of the genital tract epithelium is
indicated with a white line. All images are confocal Z-scans collected using a 106 (A to C), 206 (G to L) and 606objective (D to F). Bars: (A to C)
100 microns, (G to L) 50 microns and, (D to F) 20 microns.
doi:10.1371/journal.pone.0004131.g002
Localized CD8low/2 T Cells
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or less than 0.08% of the CD3+ lymphocytes isolated from lymph
nodes and were not above the levels of background staining with
negative control tetramers loaded with an irrelevant peptide
(Figure 5), nor were tetramer+CD82 populations without gating
on CD3 (data not shown). However, we consistently saw
populations of tetramer+CD3+CD8low cells above levels of
negative control tetramer staining (Figure 5). To better compare
results from in situ tetramer staining with flow cytometry, we
calculated the percentage of tetramer+ cells that were CD8+,
CD8low, and CD82 within the lymph nodes and vagina tissues
using in situ tetramer staining and flow cytometry. Because the
vaginal tissues processed for flow cytometry had the epithelium
removed and thus only contained cells from the submucosa, for
this comparison we only included cells in the submucosa or border
of the submucosa for our in situ tetramer staining calculations.
The results showed no statistically significant differences in the
populations tetramer+CD8+, tetramer+CD8low, and tetra-
mer+CD82 cells calculated via in situ tetramer staining compared
to flow cytometry (Figure 6), indicating that the populations
detected via in situ tetramer staining are also detected using flow
cytometry.
The presence of tetramer+CD8low/2 cells in situ was not
affected by route of inoculation or time post-infection
In this study we examined tissues from animals that were vaginally
inoculated and animals that were rectally inoculated with SIV-
mac239. We also examined tissues from animals that were sacrificed
at relatively early and late post-infection. Tetramer+ CD8low/2 cells
were identified in both vaginally and rectally inoculated rhesus
macaques early after infection (Table 1), indicating that the route of
inoculation does not affect the formation of this novel subpopulation
of cells. Tetramer+ CD8low/2 cells were also present in lymph nodes
Figure 3. Concentration and localization of SIV-specific CD8 T cells in lymph nodes and vagina. This figure shows the concentration
(cells/mm2) of tetramer+ cells that were CD8+, CD8low, and CD82 found in CD8 rich and in CD8 low/negative regions of lymph nodes [30], and within
the submucosa, border of the submucosa, and within the epithelium of vagina sections (B). (C) and (D) show the percentage of tetramer+ cells that
are CD8+, CD8low and CD82 within each tissue area. All lymph nodes were axillary with the exception of sections from animal #R80072 in which
axillary and mesenteric lymph nodes were stained together. Results of t-tests comparing the percentages of each cell type (CD8+, CD8low and CD82)
found in CD8 rich areas to CD8 low/negative areas of lymph nodes (C), and comparing the percentages of each cell type in the submucosa, to the
percentage of cells found in the border of the submucosa and in the submucosa compared to the epithelium in the vagina (D) that showed p-values
of ,0.001 are indicated with ***, ,0.01 with **, and ,0.05 with *.
doi:10.1371/journal.pone.0004131.g003
Localized CD8low/2 T Cells
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and genital tract early and late post-infection (Table 1) indicating that
time post-infection did not affect this novel population of cells.
Tetramer+ CD8low/2 cells are not likely NK cells, B cells,
CD4+T cells or cd T cells
To determine whether tetramer+CD8low/2 cells were possibly
NK cells non-specifically binding MHC class I tetramers, tissue
sections were stained with negative control tetramers loaded with a
peptide derived from the hepatitis B virus core. These stained
sections did not show populations of tetramer+CD8low/2 cells as
were detected with the Gag CM9 and Tat SL8 tetramers
(Figure 1f–h, Figure 2j–l, Figure 3). These data indicate that the
tetramer+CD8low/2 cells were not NK cells non-specifically
binding tetramers. To determine whether the tetramer+CD8low/2
cells were possibly B cells, cd TCR T cells, or CD4+ T cells, we
stained tissue sections with anti-human CD20 (Figure 3), cd TCR
(Figure 7), and CD4 (Figure 8) antibodies and tetramers. Tetramer+
cells in lymph nodes and the genital tract were not counterstained
with any of these antibodies indicating that tetramer+CD8low/2 cells
detected in situ are none of these cell types.
Discussion
CD8 molecules on T cells are associated with signal transduc-
tion through the interaction between peptide MHC class I
complex and T cell receptor (TCR), leading to T cell activation
[17]. Once activated, CD8+ T cells can kill cells that express the
specific MHC-class I molecules and peptide recognized by T cell
receptors [18]. We have previously reported that MHC class I
tetramers bound to viral peptides can be used to detect virus-
specific T cells in situ in tissues from rhesus macaques infected with
SIV and lymph nodes from individuals infected with HIV [12–15].
We found that the majority of tetramer staining cells in situ
expressed CD8 molecules and localized to T cells zones. Here, we
describe the observation of small localized subpopulations of cells
that stain with tetramers but are CD8low/2 in situ. These cells
were observed in lymph node, spleen, vagina, and cervix tissues. In
Table 1. Presence of tetramer+CD8low/2 cells in tissues from SIV-infected rhesus macaques.
Animal # Days post infection Inoculation site Vagina/Cervix Lymph Nodes Spleen
84089 21 dpi rectum Yes Yes N/A
27028 21 dpi vagina Yes Yes N/A
27357 21 dpi vagina Yes Yes N/A
R80072 21 dpi rectum Yes Yes Yes
27572 27 dpi vagina N/A Yes N/A
24225 28 dpi vagina Yes Yes N/A
27388 28 dpi vagina Yes Yes N/A
rh1919 28 dpi rectum Yes Yes Yes
80025 98 dpi rectum N/A Yes N/A
87108 105 dpi rectum Yes Yes N/A
R96111 396 dpi rectum Yes N/A N/A
N/A= not available. We could not distinguish the genital epithelium from lamina propria in sections from animals 27572 and 80025.
doi:10.1371/journal.pone.0004131.t001
Figure 4. Localization of SIV-specific T cells in B cell follicle. In each set of panels, the left images (A and D) show Mamu-A*01 Gag CM9
tetramer staining (red), the middle images (B and E) show CD20 antibody staining (green), and right images (C and F) are merged image of the left
and middle images. The bottom panels shows a higher magnification image taken from within the large B cell follicle shown in the top panels. The
white arrows point to a tetramer+CD202 cell within the B cell follicle. Representative images are from an axillary lymph node from animal #24225 at
28 day post-infection. Confocal images were collected using a 206 (A to C) and 606 objective (D to F). Bars: (C) 50 microns, (F) 20 microns.
doi:10.1371/journal.pone.0004131.g004
Localized CD8low/2 T Cells
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lymph node and spleen tissues, these cells often appeared to be in
or next to B cell follicles. In genital tissues, tetramer+CD8low/2
cells were primarily localized within the epithelium or near the
border of the epithelium and submucosa.
Tetramer+CD8low/2 subpopulations of cells were detected in
lymph node, spleen, vagina and cervix tissues at both early and
late time points post-infection (Table 1). Tetramer+CD8low/2 cells
were also detected in rhesus macaques that were vaginally or
rectally inoculated. These findings suggest that the time post-
infection and route of inoculation did not affect the presence and
histological pattern of tetramer-stained cells showing little to no
detectible CD8 molecules on their cell surfaces.
In order to confirm the specificity of tetramer staining, we used
MHC class I Mamu A*01 tetramers loaded with the irrelevant
peptide (FLPSDYFPSV) from viral hepatitis B virus core protein
as a negative control. This allowed us to distinguish between
specific and nonspecific staining in our experiments. Sections
stained with the negative control tetramers did not show clusters of
tetramer+CD8low/2 cells as was found in sections stained with
virus-specific tetramers. These results indicate that the tetra-
mer+CD8low/2 cells detected in situ in our experiments were not
NK cells that non-specifically bound to the MHC class I molecules
in the MHC class I tetramers.
Although it is unlikely that the tetramer+ CD8low/2 cells
detected in our experiments were cd T cells because these cells are
not MHC-class I restricted [19], and most simian cd T cells
express CD8 molecules [20], we nonetheless set out to eliminate
this possibility. It is 1) conceivable that some cd T cells might
recognize a peptide presented by classical class I MHC proteins or
MHC class I like proteins that is generally characteristic for ab T
cells [21] and 2) known that most cd T cells are CD8low/2
negative in humans [22]. We found that tetramer stained cells
were not co-labeled with cd TCR-antibodies in lymph nodes or
the genital tract, indicating that the tetramer+ CD8low/2 cells were
not cd T cells.
Tetramer+ CD8low/2 cells in secondary lymphoid organs often
appeared to be located near or within the B cell follicles. Although
most tetramer stained cells were CD8+ and localized in T cell
zones, the observed tetramer+ CD8low/2 cells tended to localize in
non-T cells zones that resembled B cell follicles in lymph node and
spleen tissues. Sections stained with tetramers and CD20
antibodies showed that there were indeed small populations of
Figure 5. Tetramer+CD3+CD8low/2 stained cells from disaggregated lymph nodes and vagina analyzed by flow cytometry.
Disaggregated cells from SIV-infected macaques were stained with Mamu-A*01 Gag CM9, Mamu-A*01 Tat SL8, and negative control Mamu-A*01 FLP
tetramers; counterstained with CD3 and CD8 antibodies and analyzed by flow cytometry. Populations of SIV-specific tetramer+CD3+CD8low/2
lymphocytes were not detected above negative control staining. However, populations of tetramer+CD3+CD8low cells were detected above
background levels. Representative data from inguinal lymph node from animal #R80072, and vaginal submucosa from #27338 is shown. Note
negative control staining FLP was not done with the vaginal submucosal cells.
doi:10.1371/journal.pone.0004131.g005
Localized CD8low/2 T Cells
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tetramer+ cells located within B cell follicles in lymph tissues.
These results taken together suggest that tetramer+ CD8low/2
populations of cells in secondary lymph tissues are often localized
next to or within B cell follicles.
It is not clear what mediates localized populations of tetramer+
CD8low/2 cells, however, one possible mechanism mediating
decreased levels of CD8 on tetramer stained cells in specific tissue
locations is the relative abundance of interleukin 7 (IL-7) in specific
tissue locations. Recent findings showed that IL-7 modulates CD8
levels on T cells, and high IL-7 levels lead to increased levels of
CD8 expression [23]. It has also recently been shown that in
secondary lymphoid organs IL-7 is expressed predominantly by
fibroblastic reticular cells in the T cell zone [24]. Thus, decreased
CD8 levels detected on tetramer stained localized to non-T cell
zones, may be a consequence of decreased IL-7 levels. In addition,
TCR signaling leads to lower levels of surface CD8 molecules
[23,25,26]. Furthermore, B cell follicles contain many antigen
presenting cells that antigen-specific T cells within B cell follicles
come into contact with. It is also therefore possible that
tetramer+CD8low/2 cells detected in situ were undergoing TCR
engagement and as a consequence showed decreased CD8 levels.
Thus, local IL-7 levels and TCR engagement are both possible
mechanisms that may contribute to the observed tetramer+C-
D8low/2 cells.
It is not clear why there exist localized populations of tetramer+
CD8low/2 cells. Because CD8 molecules are associated with TCR
signaling and T cell function, one can reason that tetramer+
CD8low/2 cells have altered function relative to tetramer+
Figure 7. Localization of SIV-specific T cells and cd TCR+ cells in lymph node and vagina. In each set of panels, the left images (A and D)
are Mamu-A*01 Gag CM9 tetramer stain (red), the middle image (B and E) are cd TCR antibody stain (green), and right images (C and F) are merged
images of the left and middle images. Panels A to F are representative images from animal #27572 that show staining in inguinal lymph node and
vagina at 27 day post-infection. Images are all confocal Z-scans collected using a 206 objective. Bar = 50 microns.
doi:10.1371/journal.pone.0004131.g007
Figure 6. Comparison of populations observed via in situ tetramer staining to flow cytometry. The percentage of tetramer+ cells that
were CD8+, CD8low, and CD82 within lymph nodes (A) and vagina submucosa tissues (B) using in situ tetramer staining and flow cytometry. For in situ
tetramer staining, all lymph nodes were axillary with the exception of animal #R80072 in which axillary and mesenteric lymph nodes were stained
together. For flow cytometry, all lymph nodes were axillary except #27338 which was inguinal.
doi:10.1371/journal.pone.0004131.g006
Localized CD8low/2 T Cells
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CD8highcells. Quigley et al., recently showed that a subset of CD8+
T cells express the chemokine receptor CXCR5 and localize to B
cell follicles in human tonsils [27]. The CXCR5+CD8+ T cells
showed an early effector non-cytolytic memory phenotype. When
stimulated in vitro these cells expressed the B cell interacting
molecules CD70, OX40 and ICOS, and these cells also supported
the survival of B cells in culture suggesting a role of memory CD8
T cells in B cell follicles. Also, recent studies by Khanna et al, used
in situ tetramer staining to determine the kinetics and localization
of antigen-specific CD8 T cells in spleens of Listeria monocytogenes-
infected mice [28]. They showed that 60% of the memory
tetramer+ CD8+ T cells localized to B cell follicles in the spleen,
and 48-hours post-restimulation the cells migrated out of the B cell
follicle and into the T cell zone and red pulp. These studies suggest
that the SIV-specific tetramer stained cells we detect in B cell
follicles from SIV-infected rhesus macaques may be SIV-specific
memory T cells.
To our knowledge, this is the first description of localized
subpopulations of tetramer+ CD8low/2 cells identified in tissues.
These findings have important implications for understanding CD8
T cell function, and for understanding the role of CD8 T cells in the
immunopathogenesis of HIV and other infectious diseases involving
infections that take place within lymphoid follicles and within the
genital epithelium. These findings suggest a model in which antigen-
specific CD8+ T cells down-modulate CD8 upon entering B cell
follicles or upon entering the epithelial layer of tissues in macaques
or alternatively, a model in which only cells that have down-
modulated CD8 can enter these tissue locations.
Materials and Methods
Animals
Adult female rhesus macaques (Macaca mulatta) were maintained
at the California National Primate Research Center and the
Wisconsin National Primate Research Center in accordance with
the regulations of the American Association of Accreditation of
Laboratory Animal Care standards. The study was approved by
local institutional animal use and care as well as biosafety review
boards. We investigated Mamu-A*01 rhesus monkeys that were
either intravaginally or intrarectally infected with SIVmac239 and
sacrificed either during the acute or chronic stages of infection as
previously described [12,16,29]. Freshly dissected lymph nodes,
spleen, vagina and cervix tissues were shipped on ice in RPMI
containing 100 mg/ml heparin over night from either the National
Primate Research Center in either California or in Wisconsin to
the Skinner lab in Minnesota.
In situ tetramer and immunohistochemical staining
Fresh lymph nodes, spleen, vaginal and cervical tissues were
used throughout these studies. In situ tetramer staining was
performed essentially as previously described [11,12] to detect
SIV-specific T cells in tissues from rhesus macaques. We
purchased biotinylated Mamu-A*01 molecules loaded with SIV
gag (CTPYDINQM) peptides (Immunomics), and loaded with
SIV tat (STPESANL) and irrelevant (FLPSDYFPSV) peptides
(National Institute of Allergy and Infectious Diseases tetramer
facility). Tetramers were generated by adding six aliquots of FITC-
labeled ExtraAvidin (Sigma) to biotinylated Mamu-A*01/b2m/
peptide monomers over the course of 8 h to a final molar ratio of
4.5:1. For in situ tetramer staining, fresh tissues were cut into
approximately 0.5-cm pieces and embedded in 4% low-melt
agarose. Tissue blocks were placed in a vibratome bath containing
0 to 4uC PBS with 100 ug/ml heparin (PBS-H), and 200 um thick
sections were generated. Sections were incubated at 4uC overnight
with tetramers (0.5 ug/ml) and either mouse anti-human CD8
alpha chain (Dako clone DK25), CD20 (Novocastra Laboratories
Ltd), CD4 (Lab Vision clone 1F6), or cd TCR (Biosciences)
antibodies diluted 1:200 in PBS-H with 2% normal goat serum
(NGS). Sections were then washed with chilled PBS-H and fixed
with 4% paraformaldehyde for 2 h at room temperature. Sections
were again washed with PBS-H, incubated with rabbit anti-FITC
antibodies (BioDesign) diluted 1:10,000 in PBS-H with 2% NGS,
and incubated at 4uC on a rocking platform overnight. Sections
were washed three times with PBS-H for at least 20 min and then
incubated with Cy3-conjugated goat anti-rabbit antibodies diluted
1:5000 (Jackson ImmunoResearch) and Alexa 488-conjugated
goat anti-mouse antibodies diluted 1:2000 (Molecular Probes), in
PBS-H with 2% NGS, for 1 to 3 days. Finally, sections were
washed three times for at least 20 min in PBS-H, post-fixed with
4% paraformaldehyde for 1 h, and then mounted on slides with
warmed glycerol gelatin (Sigma) containing 4 mg/ml n-propyl
galate. Stained sections were analyzed using a Bio-Rad 1000 or
1024 confocal microscope. Digital images were collected and
analyzed using Confocal Assistant version 4.02 and Adobe
Photoshop 7.01.
Figure 8. Localization of SIV-specific T cells and CD4+ T cells in lymph node. In each set of panels, the left images (A and D) show Mamu-
A*01 Gag181–189 CM9 tetramer staining (red), the middle images (B and E) show CD4 antibody staining (green), and right images (C and F) are
merged images of the left and middle images. Images are from a genital lymph node of animal #28850. Confocal images collected using a 206
objective (A to C) and 606objective (D to F). Bars: (A to C) 50 microns, (D to F) 20 microns.
doi:10.1371/journal.pone.0004131.g008
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Quantitative Image Analysis
For each tissue section stained with tetramers and CD8
antibodies, images were collected with an Olympus FluoView1000
confocal microscope using a 206 objective. At least three fields
were collected for each tissue, and if possible more fields (as many
as 9) were collected. Using FluoView software, tetramer positive
cells were scored in each image as being CD8+, CD8low and
CD82. Tetramer+CD8low cells were defined as showing levels of
CD8 staining in the membrane that was just above background
levels, and tetramer+CD82 cells were defined as cells that showed
no CD8 staining in the membrane above background levels. The
location of cells within tissues was also noted. Cells in lymph nodes
were scored as being either in a CD8+ rich region, or within a
spherical region with few CD8 T cells near the cortex of the tissue
resembling a B cell follicle. In the vagina, cells were scored as
being in the submucosa, near the border of the submucosa and
epithelium or within the epithelium. Cells near the border of the
submucosa were defined as cells in the submucosa that were within
30 um (approximately three cells) from the border of the
submucosa and epithelium. In addition, to quantify the number
of times clusters of tetramer+CD8low/2 cells were present in
apparent B cells follicles, we examined lymph node sections for
regions with B cell morphology (little CD8 staining, spherical, and
near the cortex) and collected a z-scan through the middle of the
apparent follicle and scored the number of tetramer+CD8low/2.
Statistical analysis was done using a two-tailed T-test.
Flow Cytometry of Tetramer stained cells
To determine the proportion of cells that were CD3+ tetramer+
and CD8low/2 cells in populations of lymphocytes isolated from
lymph node and vagina tissues we performed tetramer staining as
previously described [12]. Briefly, frozen lymphocytes from lymph
nodes were thawed and washed twice with RPMI (Cambrex) with
10% fetal bovine serum. Then 56105–16106 cells were incubated
with Mamu-A*01/Gag CM9, Mamu-A*01/Tat SL8, or Mamu-
A*01/FLP tetramers labeled with phycoerythrin for 1 hour at
37uC. The lymphocytes were then incubated with anti-human
CD3e-FITC (SP34; Pharmingen) and anti-CD8a-PerCP (clone
SK1; Becton Dickinson) for 40 min at room temperature. Similar
staining with Gag CM9 and Tat SL8 tetramers was performed
with cells from the vaginal submucosa. Data collection and
analysis was performed using a FACSCalibur flow cytometer
(Becton Dickinson) and FlowJo software (Treestar Inc.), respec-
tively.
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